CGON logo

CG Oncology, Inc. (CGON) EBITDA

annual EBITDA:

-$114.63M-$59.20M(-106.80%)
December 31, 2024

Summary

  • As of today (July 13, 2025), CGON annual EBITDA is -$114.63 million, with the most recent change of -$59.20 million (-106.80%) on December 31, 2024.
  • During the last 3 years, CGON annual EBITDA has fallen by -$102.26 million (-826.11%).
  • CGON annual EBITDA is now -826.11% below its all-time high of -$12.38 million, reached on December 1, 2021.

Performance

1-year change

-106.8%

3-year change

-826.11%

5-year change

-826.11%

15-year change

-826.11%

CGON EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector rank

15.22%
CGON annual EBITDA is higher than 15.22% of companies in Healthcare sector

Range

All-time high

-$12.38M

3-year low

-$114.63M
CGON annual EBITDA is currently at its 3-year low

Earnings dates

Last annual earnings report date

Dec 31, 2024
CGON previous annual earnings announcement was published on Dec 31, 2024

Next annual earnings report date

N/A
CGON next annual earnings announcement has not yet been scheduled

OtherCGONincome statement metrics

Annual revenue

$1.14M
CGON annual revenue is $1.14 million

annual net income

-$88.04M
CGON annual net profit is -$88.04 million

annual EBIT

-$114.67M
CGON annual earnings before interest & taxes is -$114.67 million

Annual EPS

-$1.41
CGON annual earnings per share is -$1.41

quarterly EBITDA:

-$42.18M-$4.13M(-10.86%)
March 31, 2025

Summary

  • As of today (July 13, 2025), CGON quarterly EBITDA is -$42.18 million, with the most recent change of -$4.13 million (-10.86%) on March 31, 2025.
  • Over the past year, CGON quarterly EBITDA has dropped by -$19.71 million (-87.76%).
  • CGON quarterly EBITDA is now -353.01% below its all-time high of -$9.31 million, reached on December 1, 2022.

Performance

3-month change

-10.86%

1-year change

-87.76%

3-year change

-353.01%

5-year change

-353.01%

CGON quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector rank

10.58%
CGON quarterly EBITDA is higher than 10.58% of companies in Healthcare sector

Range

All-time high

-$9.31M

3-year low

-$42.18M
CGON quarterly EBITDA is currently at its 3-year low

Earnings dates

Last quarterly earnings report date

Mar 31, 2025
CGON previous earnings announcement was published on Mar 31, 2025

Next quarterly earnings report date

Aug 8, 2025
CGON next earnings announcement is scheduled for Aug 8, 2025

OtherCGONincome statement metrics

Quarterly revenue

$52.00K
CGON quarterly revenue is $52.00 thousand

quarterly net income

-$34.45M
CGON quarterly net profit is -$34.45 million

quarterly EBIT

-$42.20M
CGON quarterly earnings before interest & taxes is -$42.20 million

Quarterly EPS

-$0.45
CGON quarterly earnings per share is -$0.45

TTM EBITDA:

-$134.35M-$19.71M(-17.20%)
March 31, 2025

Summary

  • As of today (July 13, 2025), CGON TTM EBITDA is -$134.35 million, with the most recent change of -$19.71 million (-17.20%) on March 31, 2025.
  • Over the past year, CGON TTM EBITDA has dropped by -$66.17 million (-97.06%).
  • CGON TTM EBITDA is now -1342.91% below its all-time high of -$9.31 million, reached on December 1, 2022.

Performance

3-month change

-17.2%

1-year change

-97.06%

3-year change

-1342.91%

5-year change

-1342.91%

CGON TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector rank

13.93%
CGON TTM EBITDA is higher than 13.93% of companies in Healthcare sector

Range

All-time high

-$9.31M

3-year low

-$134.35M
CGON TTM EBITDA is currently at its 3-year low

Earnings dates

Last quarterly earnings report date

Mar 31, 2025
CGON previous earnings announcement was published on Mar 31, 2025

Next quarterly earnings report date

Aug 8, 2025
CGON next earnings announcement is scheduled for Aug 8, 2025

OtherCGONincome statement metrics

TTM revenue

$662.00K
CGON TTM revenue is $662.00 thousand

TTM net income

-$105.56M
CGON TTM net profit is -$105.56 million

TTM EBIT

-$134.40M
CGON TTM earnings before interest & taxes is -$134.40 million

TTM EPS

-$1.51
CGON TTM earnings per share is -$1.51

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

annual EBITDA

-$114.63M
CGON annual EBITDA is -$114.63 million

annual net income

-$88.04M
CGON annual net profit is -$88.04 million

annual interest expense

-
CGON annual interest expense value is unknown

annual income tax

-
CGON annual income tax value is unknown

annual D&A

$32.00K
CGON annual depreciation & amortization is $32.00 thousand

CGON EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-106.8%-87.8%-97.1%
3 y3 years-826.1%-353.0%-1342.9%
5 y5 years-826.1%-353.0%-1342.9%

CGON EBITDA Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-826.1%at low-353.0%at low-1342.9%at low
5 y5-year-826.1%at low-353.0%at low-1342.9%at low
alltimeall time-826.1%at low-353.0%at low-1342.9%at low

CGON EBITDA History

DateAnnualQuarterlyTTM
Mar 2025
-
-$42.18M(+10.9%)
-$134.35M(+17.2%)
Dec 2024
-$114.63M(+106.8%)
-$38.05M(+34.6%)
-$114.63M(+19.5%)
Sep 2024
-
-$28.27M(+9.4%)
-$95.94M(+17.4%)
Jun 2024
-
-$25.85M(+15.1%)
-$81.70M(+19.8%)
Mar 2024
-
-$22.46M(+16.1%)
-$68.18M(+23.0%)
Dec 2023
-$55.43M
-$19.35M(+37.8%)
-$55.43M(+22.1%)
DateAnnualQuarterlyTTM
Sep 2023
-
-$14.04M(+13.9%)
-$45.39M(+44.8%)
Jun 2023
-
-$12.32M(+26.8%)
-$31.35M(+64.8%)
Mar 2023
-
-$9.72M(+4.4%)
-$19.03M(+104.4%)
Dec 2022
-$35.23M(+184.6%)
-
-
Dec 2022
-
-$9.31M
-$9.31M
Dec 2021
-$12.38M
-
-

FAQ

  • What is CG Oncology, Inc. annual EBITDA?
  • What is the all time high annual EBITDA for CG Oncology, Inc.?
  • What is CG Oncology, Inc. annual EBITDA year-on-year change?
  • What is CG Oncology, Inc. quarterly EBITDA?
  • What is the all time high quarterly EBITDA for CG Oncology, Inc.?
  • What is CG Oncology, Inc. quarterly EBITDA year-on-year change?
  • What is CG Oncology, Inc. TTM EBITDA?
  • What is the all time high TTM EBITDA for CG Oncology, Inc.?
  • What is CG Oncology, Inc. TTM EBITDA year-on-year change?

What is CG Oncology, Inc. annual EBITDA?

The current annual EBITDA of CGON is -$114.63M

What is the all time high annual EBITDA for CG Oncology, Inc.?

CG Oncology, Inc. all-time high annual EBITDA is -$12.38M

What is CG Oncology, Inc. annual EBITDA year-on-year change?

Over the past year, CGON annual EBITDA has changed by -$59.20M (-106.80%)

What is CG Oncology, Inc. quarterly EBITDA?

The current quarterly EBITDA of CGON is -$42.18M

What is the all time high quarterly EBITDA for CG Oncology, Inc.?

CG Oncology, Inc. all-time high quarterly EBITDA is -$9.31M

What is CG Oncology, Inc. quarterly EBITDA year-on-year change?

Over the past year, CGON quarterly EBITDA has changed by -$19.71M (-87.76%)

What is CG Oncology, Inc. TTM EBITDA?

The current TTM EBITDA of CGON is -$134.35M

What is the all time high TTM EBITDA for CG Oncology, Inc.?

CG Oncology, Inc. all-time high TTM EBITDA is -$9.31M

What is CG Oncology, Inc. TTM EBITDA year-on-year change?

Over the past year, CGON TTM EBITDA has changed by -$66.17M (-97.06%)
On this page